Albireo Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Albireo Pharma's past years’ income statements indicate that its last revenue has increased compared to the previous period by 388% to $40,579,000. Profit margin reached -373%. Total operating expenses were $162,708,000.
Profit Margin
| 2012 | 0 | -20.74M | |
|---|---|---|---|
| 2013 | 0 | -19.33M | |
| 2014 | 0 | -14.13M | |
| 2015 | 0 | -18.73M | |
| 2016 | 11.36M | -16.35M | -143.88% |
| 2017 | 1K | -24.41M | -2441400% |
| 2018 | 12.74M | -46.11M | -361.94% |
| 2019 | 9.63M | -71.70M | -744.13% |
| 2020 | 8.30M | -118.99M | -1432.29% |
| 2021 | 40.57M | -151.34M | -372.97% |
ALBO Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 40.57M | 8.30M | 9.63M | 12.74M | 1K | 11.36M | 0 | 0 | 0 | 0 |
Cost of revenue | 1.35M | 0 | 2.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 39.22M | 8.30M | 7.42M | 12.74M | 1K | 11.36M | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 82.52M | 76.77M | 45.57M | 31.73M | 12.99M | 8.07M | 13.36M | 14.19M | 14.29M | 12.57M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 162.70M | 104.57M | 70.74M | 50.63M | 24.57M | 23.65M | 19.76M | 19.26M | 20.59M | 19.29M |
Operating income | -123.48M | -96.27M | -61.11M | -37.89M | -24.57M | -12.29M | -20.77M | -24.36M | -20.53M | -19.29M |
Other income (expenses), net | 89.45M | -11.36M | -1.60M | -8.20M | 375K | -2.67M | 2.06M | 10.26M | 1.21M | -1.43M |
Income before tax | -34.03M | -107.63M | -62.71M | -46.09M | -24.20M | -16.28M | -18.70M | -14.10M | -19.32M | -20.72M |
Income tax expense | 117.31M | 11.36M | 8.98M | 20K | 212K | 62K | 29K | 26K | 15K | 18K |
Net income | -151.34M | -118.99M | -71.70M | -46.11M | -24.41M | -16.35M | -18.73M | -14.13M | -19.33M | -20.74M |
Earnings per share | ||||||||||
Basic EPS | -7.87 | -7.45 | -5.77 | -3.94 | -3.12 | -13.19 | -13.7 | -19.81 | -37.06 | -57.30 |
Diluted EPS | -7.87 | -7.45 | -5.77 | -3.94 | -3.12 | -13.19 | -13.7 | -19.81 | -37.06 | -57.30 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |